Pricing Log in Create free account

Belite Bio, Inc. Sponsored ADR (BLTE) vs Ligand Pharmaceuticals Incorporated (LGND)

Belite Bio, Inc. Sponsored ADR and Ligand Pharmaceuticals Incorporated are both Biotechnology companies. Belite Bio, Inc. Sponsored ADR and Ligand Pharmaceuticals Incorporated are of similar size ($6.2B and $6.0B). Belite Bio, Inc. Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Ligand Pharmaceuticals Incorporated trades at 29.5×. Ligand Pharmaceuticals Incorporated has the higher net margin (67.9% vs 0.00%) and the higher return on invested capital (8.19% vs −9.55%). Across the 13 metrics below, Ligand Pharmaceuticals Incorporated leads on 11 and Belite Bio, Inc. Sponsored ADR on 2.

Valuation

Metric BLTE LGND Biotechnology median
P/E n/m 29.52 8.50
P/S n/m 20.41 9.71
P/B 7.45 6.13 2.13
Price to free cash flow n/m 41.36 20.82
EV/EBITDA n/m 46.38 0.64
EV/Sales n/m 19.83 9.21
Earnings yield (1.91%) 3.39% (33.15%)
Free cash flow yield (1.16%) 2.42% (25.50%)

Profitability

Metric BLTE LGND Biotechnology median
Gross margin — 95.43% 65.16%
Operating margin 0.00% 32.61% 0.00%
Net margin 0.00% 67.88% 0.00%
Free cash flow margin 0.00% 49.34% 0.00%
Return on equity 0.00% 21.96% (56.36%)
Return on assets (21.60%) 12.58% (48.04%)
Return on invested capital (9.55%) 8.19% 0.00%

Growth

Metric BLTE LGND Biotechnology median
Revenue growth (TTM) — 54.89% 6.02%
EPS growth (last fiscal year) (95.76%) 2,886.36% 30.26%
Revenue growth, 5-year CAGR — 10.39% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BLTE LGND Biotechnology median
Debt to equity 0.00 1.16 0.00
Current ratio 33.56 31.18 4.72
Net debt to EBITDA 5.88 (4.36) 0.96

Dividend

Metric BLTE LGND Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BLTE LGND Biotechnology median
Market cap 6.15b 5.95b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack